À retenir
In a pilot trial of 20 head and neck cancer patients with cachexia (wasting), all completed machine-based resistance training or usual care during radiotherapy, with no serious adverse events and gains in training loads of 19.0% to 29.8%. Changes in fatigue, quality of life and fitness were not statistically significant, so this shows feasibility, not benefit.
Study design
Essai randomisé
Reading basis
Published abstract
Reading focus
Comparator & uncertainty
Cette explication éditoriale existe en anglais, chinois simplifié et chinois traditionnel. Cette interface affiche la lecture en anglais.
Question de recherche
Cachexia, the loss of muscle and body weight in advanced cancer, harms physical function, and radiotherapy adds to the burden. The authors tested whether progressive resistance training is practical and safe in cachectic head and neck cancer patients during radiotherapy, and looked for early signs of benefit or harm.
Population et méthode
Pilot randomized controlled trial in 20 cachectic patients receiving radiotherapy for head and neck cancer, randomized to machine-based progressive resistance training (n = 10) or usual care (n = 10). Training took place 3 times weekly for 30 minutes: 3 exercises for major muscle groups, 3 sets of 8-12 repetition maximum each. Outcomes were bioelectrical impedance analysis, hand-held dynamometry (grip strength), the Six-Minute Walk Test, and questionnaires for fatigue and quality of life, measured before radiotherapy (t1), after 7 weeks of radiotherapy (t2) and 8 weeks after radiotherapy ended (t3). The trial was registered retrospectively.
Résultats
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1All 20 participants completed the trial and no serious adverse events occurred. Participants in the training group attended at least 13 sessions.
- 2Before radiotherapy the patients had already lost 7.1 ± 5.2% of body weight, and fatigue (score 10.7 ± 3.3) and reduced quality of life (score 71.3 ± 20.6) were common.
- 3In the training group the weight lifted rose on average by 19.0% on the leg press, 29.8% on the chest press and 22.8% on the latissimus pull-down.
- 4Outcome measures changed non-significantly at t2 and t3. There was a trend toward better course of general fatigue and quality of life at t2 in the training group, which the authors describe as only a trend.
Limites et incertitude
- 1With only 10 people per group, the trial was far too small to detect real differences in fatigue, quality of life or fitness.
- 2Group comparisons were non-significant, so the possible benefits for fatigue and quality of life are tentative.
- 3Registration happened after the trial started (15 May 2018, retrospective), which weakens protection against selective reporting.
- 4The abstract does not give the group-level outcome numbers, and this reading is based on the abstract only.
Mise en perspective
Supervised, machine-based strength training appears practical for people with head and neck cancer who are losing weight during radiotherapy, and adherence was high. It is not proof that it reduces fatigue or improves quality of life, and anyone in cancer treatment should plan exercise with their oncology team.
Vos données
This is a supervised clinical setting, not something to self-direct from wearable data. If your care team approves exercise, logging session attendance, weights lifted and body weight over time can show progress; compare against your own earlier entries using the same scale and equipment.
Comprendre ce type de preuve
Randomisation can support causal inference, but check allocation, blinding, missing outcomes, follow-up and the actual comparator. A trial label alone does not establish high certainty.
Résumé structuré des auteurs English
Le résumé original en anglais est reproduit avec attribution sous la licence ouverte indiquée. Il s’agit d’une source, pas d’une interprétation MoveVitals. L’analyse préparée figure ci-dessus ; vérifiez les conclusions importantes dans la source.
Background
Cancer cachexia is a prevalent symptom of head and neck neoplasms. The reduction in skeletal muscle mass is one of the main characteristics which can lead to poor physical functioning. The purposes of this pilot randomized controlled trial were to determine the feasibility of progressive resistance training in cachectic head and neck cancer patients during radiotherapy and to explore possible risks and benefits.
Methods
Twenty cachectic participants with head and neck cancer receiving radiation were randomized to obtain either a machine supported progressive resistance training (n = 10) or usual care (n = 10). The training took place 3 times weekly for 30 min. Intervention included 3 exercises for major muscle groups with 8-12 repetition maximum for 3 sets each. Bioelectrical impedance analysis, hand-held dynamometry, Six-Minute Walk Test and standardized questionnaires for fatigue and quality of life were used for evaluating outcomes at baseline before radiotherapy (t1), after 7 weeks of radiotherapy (t2) and 8 weeks after the end of radiotherapy (t3).
Results
All participants (n = 20) completed the trial. No serious adverse events occurred. At the initial assessment the cachectic patients had already lost 7.1 ± 5.2% of their body weight. General fatigue (score 10.7 ± 3.3) and reduced quality of life (score 71.3 ± 20.6) were prevalent in cachectic head and neck cancer patients even before radiotherapy. An average improvement of weight loading for leg press (+ 19.0%), chest press (+ 29.8%) and latissimus pull-down (+ 22.8%) was possible in the intervention group. Participants had at least 13 training sessions. The outcome measures showed nonsignificant changes at t2 and t3, but a trend for a better course of general fatigue and quality of life at t2 in the intervention group.
Conclusions
Despite advanced tumor stage and burdensome treatment the intervention adherence is excellent. Progressive resistance training in cachectic head and neck cancer patients during radiotherapy seems to be safe and feasible and may have beneficial effects of general fatigue and quality of life.
Trial registration
ClinicalTrials.gov, NCT03524755 . Registered 15 May 2018 - Retrospectively registered.
Sources et attribution
Progressive resistance training in cachectic head and neck cancer patients undergoing radiotherapy: a randomized controlled pilot feasibility trial.
Grote M, Maihöfer C, Weigl M, Davies-Knorr P, Belka C.
Radiation oncology (London, England) · 2018-11-06
DOI: 10.1186/s13014-018-1157-0 ↗PubMed · 30400971 ↗Europe PMC · Licence indiquée: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
Interprétation éditoriale MoveVitals · contenu éducatif · aucune évaluation clinique individuelle enregistrée
Sources vérifiées 2026-11-01
Guides pratiques
À lire ensemble
ACSM review of 137 reviews: resistance training works, and few programme details matter
The American College of Sports Medicine pooled 137 systematic reviews (over 30,000 healthy adults) and concluded that resistance training beats no exercise for strength, muscle size, power, endurance and several function tests. Few programme details changed results consistently: heavier loads (80% or more of one-repetition maximum) and 2 to 3 sets favoured strength, and at least 10 sets a week favoured muscle size, while training to failure, exercise type and periodization did not. It summarises reviews rather than new trials, gives no pooled effect sizes, and drew mostly on untrained adults and overlapping source trials.
Medicine & Science in Sports & Exercise
Nearly every resistance training plan beat no exercise; heavy loads led for strength
In a network meta-analysis of randomised trials in healthy adults (178 studies and 5097 people for strength, 119 studies and 3364 people for muscle size), nearly all resistance training prescriptions beat no exercise. Higher-load, multiset, thrice-weekly training ranked best for strength (standardised mean difference 1.60, 95% credible interval 1.38 to 1.82) and higher-load, multiset, twice-weekly training for muscle size (0.66, 0.47 to 0.85). Most prescriptions could not be statistically separated from each other (the 95% interval contained zero in 91% of the comparisons between them) and risk of bias was moderate to high, so the rankings are tentative.
British Journal of Sports Medicine
Muscle-strengthening linked to lower risk of death, heart disease, cancer and diabetes
Pooling 16 prospective cohort studies of adults, people who did muscle-strengthening activity had a 15% lower risk of all-cause mortality (RR 0.85, 95% CI 0.79 to 0.93) and a 17% lower risk of both cardiovascular disease and diabetes (RR 0.83 for each) than people who did none. The pooled mortality curve was lowest at about 40 min/week (RR 0.83), but whether larger amounts help or hurt is unclear. All of this is observational, from mostly US self-reported data, and the authors rated the certainty of evidence as very low for most outcomes.
British Journal of Sports Medicine
Protein supplements and weight training: small extra gains, smaller in older adults
Pooling 49 randomised trials with 1,863 healthy adults who did resistance training for at least 6 weeks, protein supplements added 0.30 kg of fat-free mass (95% CI 0.09 to 0.52) and 2.49 kg of one-repetition-maximum strength (0.64 to 4.33) on top of training alone. These gains were small next to the effect of training itself, were weaker with older age, and the suggested plateau near 1.6 g/kg/day was not statistically significant (p=0.079). One author has received funding from the US National Dairy Council, which supported trials in the analysis.
British Journal of Sports Medicine

